Home › NDC Lookup › RxCUI directory › RxCUI 313566

Valganciclovir 450 MG Oral Tablet — RxCUI 313566

RxNorm drug concept · Semantic clinical drug
RxCUI 313566 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 26 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313566
Official nameValganciclovir 450 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvalganciclovir 450 MG (as valganciclovir hydrochloride 496.3 MG) Oral Tablet; valGANciclovir HCl 450 MG Oral Tablet
FDA products mapped15
Package NDCs mapped26
Reported Medicaid activity (SDUD)20,856 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valganciclovir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Valganciclovir is used for two main purposes. First, it treats a serious viral eye infection called CMV retinitis in adults living with AIDS. Second, it prevents a virus called CMV...
  • You really do need to take valganciclovir with food — it's not just a suggestion. Eating a meal when you take it increases the amount of active drug your body absorbs by a meaningf...
  • Do I have to take this with food, or can I take it on an empty stomach?
  • The most common ones are diarrhea, nausea, vomiting, fever, headache, and feeling tired. Shakiness (tremor) and trouble sleeping also happen fairly often. The ones your doctor real...
📖 Read our full Valganciclovir guide →

🕸️ Concept Web — How Valganciclovir 450 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Valganciclovir 450 MG Oral Tablet RxCUI 313566

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Valganciclovir 275891
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Valcyte 304959
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Valganciclovir Oral Tablet 374656
    • Valganciclovir Oral Product 1163993
    • Valganciclovir Pill 1163994
    • Valganciclovir Oral Tablet [Valcyte] 368141
    • Valcyte Oral Product 1187139
    • Valcyte Pill 1187140
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Valganciclovir 450 MG SCDC · 331565
  • Valganciclovir Oral Tablet SCDF · 374656
  • Valganciclovir Oral Product SCDG · 1163993
  • Valganciclovir Pill SCDG · 1163994

Brand-Name Concepts

  • Valganciclovir 450 MG Oral Tablet [Valcyte] SBD · 284587
  • Valganciclovir 450 MG [Valcyte] SBDC · 575014
  • Valganciclovir Oral Tablet [Valcyte] SBDF · 368141
  • Valcyte Oral Product SBDG · 1187139
  • Valcyte Pill SBDG · 1187140
  • Valcyte BN · 304959

📦 FDA Products & Package NDCs

15 products · 26 package NDCs
26 package NDCs map to RxCUI 313566 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-6796-04 30 BLISTER PACK in 1 CARTON (0904-6796-04) / 1 TABLET, FILM... Valganciclovir Major Pharmaceuticals 2016-03-18
00904-6796-10 20 BLISTER PACK in 1 CARTON (0904-6796-10) / 1 TABLET, FILM... Valganciclovir Major Pharmaceuticals 2016-03-18
27241-0158-60 60 TABLET in 1 BOTTLE (27241-158-60) Valganciclovir Ajanta Pharma USA Inc. 2019-12-26
31722-0832-31 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-832-31) Valganciclovir Camber Pharmaceuticals, Inc. 2016-03-18
31722-0832-32 10 TABLET, FILM COATED in 1 CARTON (31722-832-32) Valganciclovir Camber Pharmaceuticals, Inc. 2016-03-18
31722-0832-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-832-60) Valganciclovir Camber Pharmaceuticals, Inc. 2016-03-18
42291-0973-60 60 TABLET, FILM COATED in 1 BOTTLE (42291-973-60) Valganciclovir AvKARE 2023-12-21
43598-0356-30 30 TABLET in 1 BOTTLE (43598-356-30) valganciclovir hydrochloride Dr. Reddy's Laboratories Inc 2017-12-12
43598-0356-60 60 TABLET in 1 BOTTLE (43598-356-60) valganciclovir hydrochloride Dr. Reddy's Laboratories Inc 2017-12-12
50268-0787-12 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-787-12) / 1 TABL... Valganciclovir AvPAK 2016-07-27
55111-0762-05 500 TABLET, FILM COATED in 1 BOTTLE (55111-762-05) Valganciclovir Dr. Reddy's Laboratories Limited 2014-12-15
55111-0762-60 60 TABLET, FILM COATED in 1 BOTTLE (55111-762-60) Valganciclovir Dr. Reddy's Laboratories Limited 2014-12-15
55111-0762-78 10 BLISTER PACK in 1 CARTON (55111-762-78) / 10 TABLET, FIL... Valganciclovir Dr. Reddy's Laboratories Limited 2014-12-15
60429-0846-60 60 TABLET, FILM COATED in 1 BOTTLE (60429-846-60) Valganciclovir Golden State Medical Supply, Inc. 2018-11-02
61269-0480-60 1 BOTTLE, PLASTIC in 1 CARTON (61269-480-60) / 60 TABLET, F... Valcyte H2-Pharma, LLC 2001-03-29
61269-0485-10 1 BOTTLE, GLASS in 1 CARTON (61269-485-10) / 100 mL in 1 BO... Valcyte H2-Pharma, LLC 2009-08-28
64380-0153-01 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-153-01) Valganciclovir Strides Pharma Science Limited 2022-09-12
64380-0161-01 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-161-01) Valganciclovir Strides Pharma Science Limited 2025-06-16
65862-0753-01 100 TABLET in 1 BOTTLE (65862-753-01) VALGANCICLOVIR HYDROCHLORIDE Aurobindo Pharma Limited 2016-03-31
65862-0753-05 500 TABLET in 1 BOTTLE (65862-753-05) VALGANCICLOVIR HYDROCHLORIDE Aurobindo Pharma Limited 2016-03-31
65862-0753-18 180 TABLET in 1 BOTTLE (65862-753-18) VALGANCICLOVIR HYDROCHLORIDE Aurobindo Pharma Limited 2016-03-31
65862-0753-60 60 TABLET in 1 BOTTLE (65862-753-60) VALGANCICLOVIR HYDROCHLORIDE Aurobindo Pharma Limited 2016-03-31
65862-0753-99 1000 TABLET in 1 BOTTLE (65862-753-99) VALGANCICLOVIR HYDROCHLORIDE Aurobindo Pharma Limited 2016-03-31
68084-0965-19 20 BLISTER PACK in 1 CARTON (68084-965-19) / 1 TABLET, FILM... Valganciclovir American Health Packaging 2024-11-06
68084-0965-25 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-965-25) / 1 TABL... Valganciclovir American Health Packaging 2015-01-16
72603-0750-01 60 TABLET in 1 BOTTLE (72603-750-01) VALGANCICLOVIR HYDROCHLORIDE NorthStar Rx LLC 2026-03-01
Observed labelers: Aurobindo Pharma Limited (5) · Camber Pharmaceuticals, Inc. (3) · Dr. Reddy's Laboratories Limited (3) · American Health Packaging (2) · Dr. Reddy's Laboratories Inc (2) · H2-Pharma, LLC (2) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.